Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA‐II), serum a‐fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non‐diagnostic serum a‐fetoprotein levels

Antonia Syriha,Spyridon Pantzios,Dionysia Mandilara,Petros Galanis,Ioanna Stathopoulou,Georgia Barla,Ioannis Elefsiniotis
DOI: https://doi.org/10.1002/cam4.6825
IF: 4.711
2024-02-17
Cancer Medicine
Abstract:Aim The aim of our study was to evaluate the accuracy of serum biomarkers (AFP/PIVKA‐II) and their combination in HCC diagnosis among Caucasian cirrhotic patients. Methods Serum AFP/PIVKA‐II levels were evaluated in 218 cirrhotics (163 males, 118 CTP‐A, 66 ALBI‐I, 111 with varices, 63 with diabetes) with (n = 90) or without (n = 128) HCC. Patients with HCC were categorized to BCLC Stage 0/A (n = 12), B (n = 21), C (n = 48), and D (n = 9). Results The two groups were comparable for all baseline parameters except for age, platelets, and diabetes presence. Median levels of AFP (239.1 vs. 4.0 ng/mL) and PIVKA‐II (4082.7 vs. 45.8 mAU/mL) were both significantly higher in HCC group compared to controls (p
oncology
What problem does this paper attempt to address?